115 related articles for article (PubMed ID: 38641011)
1. Lymphocyte Crossmatch Testing or Donor HLA-DP and -DQ Allele Typing Effectiveness in Single Cord Blood Transplantation for Patients With Anti-HLA Antibodies Other Than Against HLA-A, -B, -C, and -DRB1.
Osada M; Yamamoto H; Watanabe O; Yamaguchi K; Kageyama K; Kaji D; Taya Y; Nishida A; Ishiwata K; Takagi S; Makino S; Asano-Mori Y; Yamamoto G; Taniguchi S; Wake A; Uchida N
Transplant Cell Ther; 2024 Apr; ():. PubMed ID: 38641011
[TBL] [Abstract][Full Text] [Related]
2. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
[TBL] [Abstract][Full Text] [Related]
3. Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantation.
Jo T; Arai Y; Hatanaka K; Ishii H; Ono A; Matsuyama N; Mori J; Koh Y; Azuma F; Kimura T
Cytotherapy; 2023 Apr; 25(4):407-414. PubMed ID: 36335019
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
5. Selection of Cord Blood Unit by CD34
Morishima Y; Watanabe-Okochi N; Kai S; Azuma F; Kimura T; Matsumoto K; Hatasa S; Araki N; Miyamoto A; Sekimoto T; Minemoto M; Ishii H; Uchida N; Takahashi S; Tanaka M; Shingai N; Miyakoshi S; Kozai Y; Onizuka M; Eto T; Ishimaru F; Kanda J; Ichinohe T; Atsuta Y; Takanashi M; Kato K
Transplant Cell Ther; 2023 Oct; 29(10):622-631. PubMed ID: 37536453
[TBL] [Abstract][Full Text] [Related]
6. Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes with Donor-Specific Anti-HLA Antibodies against HLA-DP.
Uchibori Y; Onodera K; Onishi Y; Komatsu H; Takenaka K; Narumi Y; Watanabe T; Nakamura H; Sakurai K; Hashimoto K; Inokura K; Ichikawa S; Fukuhara N; Yokoyama H; Harigae H
Tohoku J Exp Med; 2023 Oct; 261(2):123-127. PubMed ID: 37558420
[TBL] [Abstract][Full Text] [Related]
7. Role of
Chowdhry M; Patel M; Thakur Y; Sharma V
Asian J Transfus Sci; 2019; 13(2):136-139. PubMed ID: 31896922
[TBL] [Abstract][Full Text] [Related]
8. Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy.
Morita-Fujita M; Shindo T; Iemura T; Arai Y; Kanda J; Okada K; Ueda Y; Yoshiyuki O; Anzai N; Mori T; Ishikawa T; Otsuka Y; Yonezawa A; Yuhi N; Imada K; Oba A; Itoh M; Okamoto Y; Kitano T; Ikeda T; Kotani S; Akasaka T; Yago K; Watanabe M; Nohgawa M; Tsuji M; Takeoka T; Yamamoto R; Arima N; Yoshinaga N; Hishizawa M; Yamashita K; Kondo T; Takaori-Kondo A;
Transplant Cell Ther; 2023 Jun; 29(6):347.e1-347.e11. PubMed ID: 36889508
[TBL] [Abstract][Full Text] [Related]
9. Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
Sanz J; Jaramillo FJ; Planelles D; Montesinos P; Lorenzo I; Moscardó F; Martin G; López F; Martínez J; Jarque I; de la Rubia J; Larrea L; Sanz MA; Sanz GF
Biol Blood Marrow Transplant; 2014 Jan; 20(1):106-10. PubMed ID: 24516896
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
Grifoni A; Moore E; Voic H; Sidney J; Phillips E; Jadi R; Mallal S; De Silva AD; De Silva AM; Peters B; Weiskopf D; Sette A
Front Immunol; 2019; 10():1568. PubMed ID: 31333679
[No Abstract] [Full Text] [Related]
11. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
[TBL] [Abstract][Full Text] [Related]
12. A Rare HLA-DRB1*14:22-DQB1*04:01 Haplotype in a Kidney Donor: Implication in the Interpretation of Donor-Specific Antibody in Kidney Transplantation-A Case Report.
Mongkolsuk T; Tammakorn C; Kitpoka P; Thammanichanond D
Transplant Proc; 2016 Apr; 48(3):943-5. PubMed ID: 27234774
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
[TBL] [Abstract][Full Text] [Related]
14. Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.
Dahi PB; Barone J; Devlin SM; Byam C; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Hsu SH; Barker JN
Biol Blood Marrow Transplant; 2014 May; 20(5):735-9. PubMed ID: 24462980
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.
Ciurea SO; Saliba RM; Rondon G; Patah PA; Aung F; Cano P; Andersson BS; Kebriaei P; Popat U; Fernandez-Vina M; Champlin RE; de Lima M
Biol Blood Marrow Transplant; 2011 Jun; 17(6):923-9. PubMed ID: 20969970
[TBL] [Abstract][Full Text] [Related]
16. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.
Elia L; Arcese W; Torello M; Iori AP; Guglielmi C; Perrone MP; Screnci M; Sprovieri T; Rapanotti MC; Cimino G
Haematologica; 1999 Jun; 84(6):530-4. PubMed ID: 10366797
[TBL] [Abstract][Full Text] [Related]
17. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
[TBL] [Abstract][Full Text] [Related]
18. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
[TBL] [Abstract][Full Text] [Related]
19. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
[TBL] [Abstract][Full Text] [Related]
20. HLA-A, B, C, DRB1, DQB1 matching heterogeneity in 'favourably matched' kidney recipients.
Rees MT; Darke C
Transpl Immunol; 2003; 12(1):73-8. PubMed ID: 14551034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
